Safety and Therapeutic Outcomes of Adjuvant Immunotherapy With Autologous Cytokine-induced Killer Cells for Patients With Hepatocellular Carcinoma Beyond Milan Criteria After Liver Transplantation
These findings advocate CIK therapy as a safe and effective, potential adjuvant treatment for HCC beyond Milan criteria after transplantation, supporting further validation trials.
Authors
- Kyung‐Suk Suh (ORCID: https://orcid.org/0000-0002-9535-7349)
- Jinsoo Rhu (ORCID: https://orcid.org/0000-0001-9809-8525)
- Suk Kyun Hong (ORCID: https://orcid.org/0000-0002-0020-6215)
- Geun Hong (ORCID: https://orcid.org/0000-0003-2597-1068)
- Jong Man Kim (ORCID: https://orcid.org/0000-0002-1903-8354)
- Jaeseok Yang (ORCID: https://orcid.org/0000-0002-1119-0407)
- Nam-Joon Yi
- YoungRok Choi
- Kwang-Woong Lee
- Dong Kyu Han
Institutions
- Seoul National University (KR)
- Yonsei University (KR)
- Severance Hospital (KR)
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Transplantation
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1097/tp.0000000000005406
- Citations
- 2
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 1.59